Biotech Biogen surges on Alzeimers drug approval
MELBOURNE: A biotech has jumped on NASDAQ following approval of a Biogen Inc. Alzheimer’s drug.
MELBOURNE: A biotech has jumped on NASDAQ following approval of a Biogen Inc. Alzheimer’s drug.
FEATURED
Online farmers markets increasing in popularity as supermarkets accused of gouging
Customer demand survey to reveal top real estate requirements for 2040
Seniors housing set to be built within historic mansion grounds
Work underway to repurpose building for affordable seniors housing
Best retirement housing designs for Global Awards shortlisted
New public housing model has created multigenerational ‘renter utopia’
INNOVATION
